Akishima Shinji
Cardiovascular Surgery, Ibaraki Prefectural Central Hospital, Kasama, JPN.
Cureus. 2025 Jun 23;17(6):e86619. doi: 10.7759/cureus.86619. eCollection 2025 Jun.
Intracardiac mass is a rare condition that poses significant diagnostic and therapeutic challenges. Regardless of the pathological diagnosis, these cases are often difficult to manage, as patients typically present with urgent clinical symptoms at their initial visit. Most symptoms result from blood flow disturbances caused by a large intracardiac tumor. Furthermore, patients face a high risk of thromboembolism. Herein, we present five cases of intracardiac masses, including three malignant tumors, encountered over approximately two years. Each case had a different pathological diagnosis: angiosarcoma (n = 2), undifferentiated pleomorphic sarcoma (n = 1), benign myxoma (n = 1), and a simple ball thrombus (n = 1). Early and accurate diagnosis and treatment, ideally complete surgical resection, is the primary approach to managing intracardiac mass. However, extensive tumor resection can be difficult to achieve while preserving adequate cardiac function, especially in advanced-stage cases. In our series, surgical resection was not indicated for two patients (one with a ball thrombus and the other with angiosarcoma) due to impaired consciousness from multiple cerebral thromboembolism or advanced-stage sarcoma. The remaining three patients, diagnosed with myxoma, angiosarcoma, and undifferentiated pleomorphic sarcoma, underwent tumor excision. However, in the two malignant cases, early recurrence occurred, and postoperative management proved to be extremely challenging. The three patients with primary cardiac sarcoma received radiation therapy combined with chemotherapy or multiple chemotherapy regimens as either primary or secondary treatment. Of the two patients diagnosed with angiosarcoma, one died two months after admission without undergoing surgery, while the other died 11 months following tumor resection, highlighting the limited effectiveness of available treatments. The remaining patient, diagnosed with undifferentiated pleomorphic sarcoma, also received combination therapy with radiation and chemotherapy. In this case, the primary in the left atrium and a solitary metastasis to the left adrenal gland were relatively controlled with proton beam therapy. In cases of intracardiac mass, early diagnosis and prompt surgical excision are crucial. If the tumor is malignant, combined treatment with radiation and chemotherapy should be promptly considered as a second-line approach based on the tumor's characteristics and the extent of surgical resection. However, there are currently no curative treatments for either malignant or benign primary cardiac tumors other than complete tumor excision. Therefore, early-stage diagnosis is directly linked to improved prognosis.
心内肿物是一种罕见病症,带来了重大的诊断和治疗挑战。无论病理诊断如何,这些病例通常都难以处理,因为患者初诊时往往伴有紧急临床症状。大多数症状是由心内大肿瘤导致的血流紊乱引起的。此外,患者面临着高血栓栓塞风险。在此,我们呈现了约两年内遇到的5例心内肿物病例,其中包括3例恶性肿瘤。每个病例都有不同的病理诊断:血管肉瘤(n = 2)、未分化多形性肉瘤(n = 1)、良性黏液瘤(n = 1)和单纯球形血栓(n = 1)。早期准确诊断并进行治疗,理想情况下是完整手术切除,是处理心内肿物的主要方法。然而,在保留足够心脏功能的同时实现广泛肿瘤切除可能很困难,尤其是在晚期病例中。在我们的系列病例中,由于多发脑栓塞导致意识障碍或肉瘤晚期,两名患者(一名患有球形血栓另一名患有血管肉瘤)未进行手术切除。其余三名被诊断为黏液瘤、血管肉瘤和未分化多形性肉瘤的患者接受了肿瘤切除。然而,在两例恶性病例中,早期复发发生,术后管理被证明极具挑战性。三名原发性心脏肉瘤患者接受了放疗联合化疗或多种化疗方案作为主要或辅助治疗。在两名被诊断为血管肉瘤的患者中,一名入院后未手术,两个月后死亡,另一名在肿瘤切除后11个月死亡,这突出了现有治疗方法的有效性有限。其余一名被诊断为未分化多形性肉瘤的患者也接受了放疗和化疗联合治疗。在这种情况下,左心房的原发肿瘤和左肾上腺的孤立转移瘤通过质子束治疗得到了相对控制。在心内肿物病例中,早期诊断和及时手术切除至关重要。如果肿瘤是恶性的,应根据肿瘤特征和手术切除范围,迅速考虑将放疗和化疗联合作为二线治疗方法。然而,目前除了完整肿瘤切除外,对于恶性或良性原发性心脏肿瘤均没有治愈性治疗方法。因此,早期诊断直接关系到预后改善。